Floatz logo

Capecitabine

Infiltrating Duct and Lobular Carcinoma In Situ

Auxilio Mutuo Cancer CenterSmall moleculePhase 2Dormant
CCC
53/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
38/ 100
Competitive Position
95/ 100

Competitive context

0 Active assets in the Infiltrating Duct and Lobular Carcinoma In Situ cohort.

Asset / SponsorPhaseRating
Docetaxel
Auxilio Mutuo Cancer Center
Phase 2CCC
TRASTUZUMAB
Auxilio Mutuo Cancer Center
Phase 2CCC
Epirubicin
Auxilio Mutuo Cancer Center
Phase 2CCC
Vinorelbine
Auxilio Mutuo Cancer Center
Phase 2CCC
Cyclophosphamide
Auxilio Mutuo Cancer Center
Phase 2CCC

Same molecule, other indications

Capecitabine is also rated in:

Locally Advanced Rectal CancerDormant
BBB
Indicative ·
75 / 100
View asset →
colorectal neoplasmDormant
BBB
Indicative ·
74 / 100
View asset →
rectal carcinomaDormant
BBB
Indicative ·
73 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →